Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials.

Date
2009-05-26
Authors
Sarzotti-Kelsoe, Marcella
Cox, Josephine
Cleland, Naana
Denny, Thomas
Hural, John
Needham, Leila
Ozaki, Daniel
Rodriguez-Chavez, Isaac R
Stevens, Gwynneth
Stiles, Timothy
Tarragona-Fiol, Tony
Simkins, Anita
Show More
(12 total)
Repository Usage Stats
100
views
72
downloads
Type
Journal article
Subject
Clinical Laboratory Techniques
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Humans
Practice Guidelines as Topic
Permalink
https://hdl.handle.net/10161/14736
Published Version (Please cite this version)
10.1371/journal.pmed.1000067
Publication Info
Sarzotti-Kelsoe, Marcella; Cox, Josephine; Cleland, Naana; Denny, Thomas; Hural, John; Needham, Leila; ... Simkins, Anita (2009). Evaluation and recommendations on good clinical laboratory practice guidelines for phase I-III clinical trials. PLoS Med, 6(5). pp. e1000067. 10.1371/journal.pmed.1000067. Retrieved from https://hdl.handle.net/10161/14736.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item record

Scholars@Duke

Denny

Thomas Norton Denny

Professor in Medicine
Thomas N. Denny, MSc, M.Phil, is the Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and the Center for HIV/AIDS Vaccine Immunology (CHAVI), and a Professor of Medicine in the Department of Medicine at Duke University Medical Center. He is also an Affiliate Member of the Duke Global Health Institute. He has recently been appointed to the Duke University Fuqua School of Business Health Sector Advisory Council. Previously, he was an Associate Professor of Pathology, Laboratory M
Sarzotti-Kelsoe

Marcella Sarzotti-Kelsoe

Research Professor of Immunology
Ongoing Applied Activities  •I direct a Global Quality Assurance Program, which I developed and pioneered here at Duke University, to oversee compliance with Good Clinical Laboratory Practice Guidelines in three HIV vaccine trial networks (CHAVI, CAVD, Duke HVTN, EQAPOL, Duke VTEU) involving domestic and international laboratory sites. •I also direct a Global Proficiency Testing Program for laboratories testing for neutralizing antibody function in individuals infected
Alphabetical list of authors with Scholars@Duke profiles.
Open Access

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy

Rights for Collection: Scholarly Articles

Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info